257 related articles for article (PubMed ID: 25500702)
1. Kidney diseases associated with anti-vascular endothelial growth factor (VEGF): an 8-year observational study at a single center.
Izzedine H; Escudier B; Lhomme C; Pautier P; Rouvier P; Gueutin V; Baumelou A; Derosa L; Bahleda R; Hollebecque A; Sahali D; Soria JC
Medicine (Baltimore); 2014 Nov; 93(24):333-339. PubMed ID: 25500702
[TBL] [Abstract][Full Text] [Related]
2. Expression patterns of RelA and c-mip are associated with different glomerular diseases following anti-VEGF therapy.
Izzedine H; Mangier M; Ory V; Zhang SY; Sendeyo K; Bouachi K; Audard V; Péchoux C; Soria JC; Massard C; Bahleda R; Bourry E; Khayat D; Baumelou A; Lang P; Ollero M; Pawlak A; Sahali D
Kidney Int; 2014 Feb; 85(2):457-70. PubMed ID: 24067439
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological spectrum of kidney diseases in cancer patients treated with vascular endothelial growth factor inhibitors: a report of 5 cases and review of literature.
Usui J; Glezerman IG; Salvatore SP; Chandran CB; Flombaum CD; Seshan SV
Hum Pathol; 2014 Sep; 45(9):1918-27. PubMed ID: 25087655
[TBL] [Abstract][Full Text] [Related]
4. All anti-vascular endothelial growth factor drugs can induce 'pre-eclampsia-like syndrome': a RARe study.
Vigneau C; Lorcy N; Dolley-Hitze T; Jouan F; Arlot-Bonnemains Y; Laguerre B; Verhoest G; Goujon JM; Belaud-Rotureau MA; Rioux-Leclercq N
Nephrol Dial Transplant; 2014 Feb; 29(2):325-32. PubMed ID: 24302609
[TBL] [Abstract][Full Text] [Related]
5. Thrombotic microangiopathy secondary to VEGF pathway inhibition by sunitinib.
Bollée G; Patey N; Cazajous G; Robert C; Goujon JM; Fakhouri F; Bruneval P; Noël LH; Knebelmann B
Nephrol Dial Transplant; 2009 Feb; 24(2):682-5. PubMed ID: 19054798
[TBL] [Abstract][Full Text] [Related]
6. Characteristic morphological changes in anti-VEGF therapy-induced glomerular microangiopathy.
Pfister F; Amann K; Daniel C; Klewer M; Büttner A; Büttner-Herold M
Histopathology; 2018 Dec; 73(6):990-1001. PubMed ID: 30014486
[TBL] [Abstract][Full Text] [Related]
7. Review of intravitreal VEGF inhibitor toxicity and report of collapsing FSGS with TMA in a patient with age-related macular degeneration.
Phadke G; Hanna RM; Ferrey A; Torres EA; Singla A; Kaushal A; Kalantar-Zadeh K; Kurtz I; Jhaveri KD
Clin Kidney J; 2021 Oct; 14(10):2158-2165. PubMed ID: 34603693
[TBL] [Abstract][Full Text] [Related]
8. Thrombotic Microangiopathy and Acute Kidney Injury Induced After Intravitreal Injection of Vascular Endothelial Growth Factor Inhibitors VEGF Blockade-Related TMA After Intravitreal Use.
Hanna RM; Tran NT; Patel SS; Hou J; Jhaveri KD; Parikh R; Selamet U; Ghobry L; Wassef O; Barsoum M; Bijol V; Kalantar-Zadeh K; Pai A; Amin A; Kupperman B; Kurtz IB
Front Med (Lausanne); 2020; 7():579603. PubMed ID: 33117836
[TBL] [Abstract][Full Text] [Related]
9. Association of vascular endothelial growth factor and renal thrombotic microangiopathy-like lesions in patients with Castleman's disease.
Sun PP; Yu XJ; Wang SX; Zhou XJ; Qu L; Zhang F; Ma YY; Liu G; Yang L
Nephrology (Carlton); 2020 Feb; 25(2):125-134. PubMed ID: 31264312
[TBL] [Abstract][Full Text] [Related]
10. Renal thrombotic microangiopathy during nintedanib treatment for idiopathic pulmonary fibrosis
.
Inoue D; Nishi H; Honda K; Ishii T; Abe H; Sato M; Nangaku M
Clin Nephrol; 2020 Jan; 93(1):47-50. PubMed ID: 31699213
[TBL] [Abstract][Full Text] [Related]
11. Focal segmental glomerulosclerosis lesion associated with inhibition of tyrosine kinases by lenvatinib: a case report.
Furuto Y; Hashimoto H; Namikawa A; Outi H; Takahashi H; Horiuti H; Honda K; Shibuya Y
BMC Nephrol; 2018 Oct; 19(1):273. PubMed ID: 30340546
[TBL] [Abstract][Full Text] [Related]
12. Kidney injury during VEGF inhibitor therapy.
den Deurwaarder ES; Desar IM; Steenbergen EJ; Mulders PF; Wetzels JF; van Herpen CM
Neth J Med; 2012 Aug; 70(6):267-71. PubMed ID: 22859418
[TBL] [Abstract][Full Text] [Related]
13. VEGF-VEGFR2 inhibitor-associated hyaline occlusive glomerular microangiopathy: a Japanese single-center experience.
Ozawa M; Ohtani H; Komatsuda A; Wakui H; Takahashi N
Clin Exp Nephrol; 2021 Nov; 25(11):1193-1202. PubMed ID: 34115234
[TBL] [Abstract][Full Text] [Related]
14. Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney.
Buob D; Decambron M; Gnemmi V; Frimat M; Hoffmann M; Azar R; Gheerbrant JD; Guincestre T; Noël C; Copin MC; Glowacki F
Kidney Int; 2016 Dec; 90(6):1321-1331. PubMed ID: 27650730
[TBL] [Abstract][Full Text] [Related]
15. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants.
Swaminathan S; Lager DJ; Qian X; Stegall MD; Larson TS; Griffin MD
Nephrol Dial Transplant; 2006 Sep; 21(9):2607-14. PubMed ID: 16705026
[TBL] [Abstract][Full Text] [Related]
16. Donor APOL1 high-risk genotypes are associated with increased risk and inferior prognosis of de novo collapsing glomerulopathy in renal allografts.
Santoriello D; Husain SA; De Serres SA; Bomback AS; Crew RJ; Vasilescu ER; Serban G; Campenot ES; Kiryluk K; Mohan S; Hawkins GA; Hicks PJ; Cohen DJ; Radhakrishnan J; Stokes MB; Markowitz GS; Freedman BI; D'Agati VD; Batal I
Kidney Int; 2018 Dec; 94(6):1189-1198. PubMed ID: 30287079
[TBL] [Abstract][Full Text] [Related]
17. Renal toxicity of anticancer agents targeting vascular endothelial growth factor (VEGF) and its receptors (VEGFRs).
Cosmai L; Gallieni M; Liguigli W; Porta C
J Nephrol; 2017 Apr; 30(2):171-180. PubMed ID: 27154025
[TBL] [Abstract][Full Text] [Related]
18. TAFRO syndrome as a cause of glomerular microangiopathy: a case report and literature review.
Nagayama Y; Yamano M; Yagame M; Nariyama T; Takahashi M; Kawamoto M; Matsui K
BMC Nephrol; 2019 Oct; 20(1):375. PubMed ID: 31623576
[TBL] [Abstract][Full Text] [Related]
19. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS; Schwimmer JA; Stokes MB; Nasr S; Seigle RL; Valeri AM; D'Agati VD
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of tyrosine kinases by sunitinib associated with focal segmental glomerulosclerosis lesion in addition to thrombotic microangiopathy.
Costero O; Picazo ML; Zamora P; Romero S; Martinez-Ara J; Selgas R
Nephrol Dial Transplant; 2010 Mar; 25(3):1001-3. PubMed ID: 20019017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
